caffeine has been researched along with cardiovascular agents in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (70.21) | 18.7374 |
1990's | 2 (4.26) | 18.2507 |
2000's | 4 (8.51) | 29.6817 |
2010's | 8 (17.02) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evenson, MA; Wiktorowicz, JE | 1 |
Kendrick, ZV; Lowenthal, DT | 1 |
Janssen, PA; Van Belle, H; Van den Broeck, WA; Wauquier, A | 1 |
Way, EL | 1 |
Carmeliet, E; Coraboeuf, E | 1 |
He, ZH; Huang, Y; Li, YX | 1 |
MEERLOO, JA | 1 |
CLAWSON, TA | 1 |
BERGSTERMANN, H; KERSCHENSTEINER, A; SCHMIDT, J | 1 |
DEL PINAL, JL; DOSAL, AF | 1 |
PIGUET, G | 1 |
SWIRSKY, MY | 1 |
MILLEN, FJ | 1 |
GRAHAM, JR | 1 |
KROLL, G | 1 |
PICHLER, E | 1 |
MAHNERT, E | 1 |
WITTICH, FW | 1 |
GERHARD, JP; MAZOUE, F | 1 |
BLUMENTHAL, LS; FUCHS, M | 3 |
BERTHET, J; FAVIER, G; VAGUE, J | 1 |
EKBOM, KA | 1 |
KRISTEK, V | 1 |
CHAKRAVARTY, DC; JONES, JW | 1 |
GAENSSLEN, H | 1 |
HIRSCHMANN, J | 1 |
MONCKTON, G | 1 |
HART, JA; HUDGSON, P | 1 |
RYAN, RE | 3 |
BOUCHARENC, G; DUBARRY, E; DUBARRY, JJ | 1 |
ZANFAGNA, PE | 1 |
Banner, NR; Birks, EJ; Hardy, J; Khaghani, A; Terracciano, CM; Yacoub, MH | 1 |
Babu, PV; Sabitha, KE; Shyamaladevi, CS; Srinivasan, P | 1 |
Clyman, RI; Roman, C | 1 |
Chary, NS; Lin, AY; Lin, CA; Tung, HH | 1 |
Cseppentō, A; Gesztelyi, R; Harmati, G; Körtvély, A; Nánási, PP; Szentmiklósi, AJ; Zsuga, J | 1 |
Jose, R; Knight, R; Pagkalos, J; Timmons, C | 2 |
Bett, GC; Kaplan, AD; Kim, JJ; Lin, B; London, B; Rasmusson, RL; Salama, G; Sun, B; Yang, L; Zhu, X | 1 |
Coombs, CJ; McCombe, DB; Wilks, DJ | 1 |
Ko, CY; Liu, MB; Qu, Z; Song, Z; Weiss, JN | 1 |
Corke, H; Gan, RY; Wang, M; Zhang, D | 1 |
4 review(s) available for caffeine and cardiovascular agents
Article | Year |
---|---|
Drug-exercise interactions.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amphetamine; Anabolic Agents; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Body Temperature; Body Temperature Regulation; Caffeine; Calcium Channel Blockers; Cardiovascular Agents; Central Nervous System; Digitalis Glycosides; Diuretics; Ethanol; Hemodynamics; Humans; Muscles; Nitrates; Physical Exertion; Salicylates; Vasodilator Agents | 1985 |
Review of reviews.
Topics: Caffeine; Cardiovascular Agents; Humans; Narcotics; Pharmacology; Psychopharmacology; Publishing; Receptors, Drug; Substance-Related Disorders | 1985 |
Xanthine derivatives in the heart: blessed or cursed?
Topics: Action Potentials; Animals; Caffeine; Cardiovascular Agents; Clinical Trials as Topic; Heart Diseases; Humans; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines | 2011 |
Health Benefits of Bioactive Compounds from the Genus
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Obesity Agents; Antineoplastic Agents; Antioxidants; Beverages; Caffeine; Camellia sinensis; Cardiovascular Agents; Carotenoids; Coffee; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Ilex; Ilex paraguariensis; Neuroprotective Agents; Plant Extracts; Polyphenols; Tea | 2018 |
43 other study(ies) available for caffeine and cardiovascular agents
Article | Year |
---|---|
Automated capillary electrophoresis applied to therapeutic drug monitoring.
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Caffeine; Cardiovascular Agents; Diuretics; Drug Monitoring; Electrophoresis; Humans; Micelles | 1992 |
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.
Topics: Administration, Oral; Animals; Caffeine; Cardiovascular Agents; Dogs; Drug Interactions; Electromyography; Electrooculography; Female; Male; Piperazines; Sleep | 1987 |
Existence of two transient outward currents in sheep cardiac Purkinje fibers.
Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Caffeine; Cardiovascular Agents; Electrophysiology; Heart; Heart Conduction System; Purkinje Fibers; Sheep | 1982 |
[Effect of caffeine and theophylline on Ca2+ sensitivity of troponin and Ca2+ release from SR in saponin-skinned rat cardiac muscle].
Topics: Animals; Caffeine; Calcium; Cardiovascular Agents; Myocardium; Rats; Saponins; Sarcoplasmic Reticulum; Stimulation, Chemical; Theophylline; Troponin | 1997 |
Combined caffeine and ergotamine in heat exhaustion.
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Heat Exhaustion; Hot Temperature; Humans; Oxytocics | 1952 |
Treatment of severe migraine with cafergot.
Topics: Caffeine; Cardiovascular Agents; Drug Combinations; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1952 |
[Studies on analgesic and spasmolytic properties of hyodon].
Topics: Analgesics; Benzoates; Caffeine; Cardiovascular Agents; Humans; Muscle Relaxants, Central; Parasympatholytics; Phenacetin; Salicylates | 1953 |
[Migraine; current concept and therapy of migrainoid neurodystonia].
Topics: Aspirin; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Migraine Disorders | 1953 |
[Combined ergotamine and caffeine in therapy of vascular headaches].
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Headache; Humans; Oxytocics; Vascular Headaches | 1953 |
Ergotamine tartrate and caffeine (EC 112) in migraine headaches.
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Migraine Disorders; Oxytocics | 1954 |
The treatment of headache with cafergot suppositories.
Topics: Caffeine; Cardiovascular Agents; Drug Combinations; Ergot Alkaloids; Ergotamine; Headache; Oxytocics; Suppositories | 1954 |
Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine.
Topics: Administration, Rectal; Alkaloids; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1954 |
[Contributions and experiences regarding ambulant asthma-Frenon therapy of resistant asthma attacks].
Topics: Asthma; Caffeine; Cardiovascular Agents; Exercise Therapy; Humans; Muscle Relaxants, Central | 1954 |
[Treatment of headache with cafergot].
Topics: Caffeine; Cardiovascular Agents; Drug Combinations; Ergot Alkaloids; Ergotamine; Headache; Migraine Disorders | 1955 |
[Pathogenesis and therapy of vascular cephalalgia].
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Headache; Migraine Disorders | 1956 |
A recent preparation for the relief of vascular headache; preliminary report.
Topics: Alkaloids; Atropa belladonna; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Gastrointestinal Agents; Headache; Humans; Parasympatholytics; Phenacetin; Vascular Headaches | 1956 |
[Favorable effect of ergotamine tartrate with caffeine on headache subsequent to gaseous electroencephalography].
Topics: Brain; Caffeine; Cardiovascular Agents; Electroencephalography; Ergot Alkaloids; Ergotamine; Headache; Humans; Radiography | 1956 |
A new agent for the control of headache.
Topics: Belladonna Alkaloids; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Headache; Humans; Oxytocics; Pentobarbital | 1957 |
[Rectal administration of ergotamine caffeine tartrate in the treatment of migraine].
Topics: Administration, Rectal; Caffeine; Cardiovascular Agents; Drug Combinations; Ergot Alkaloids; Ergotamine; Migraine Disorders; Tartrates | 1957 |
[Cafergot compound (suppositories) in therapy of migraine & Horton's syndrome].
Topics: Caffeine; Cardiovascular Agents; Cluster Headache; Drug Combinations; Ergot Alkaloids; Ergotamine; Headache; Migraine Disorders; Suppositories | 1957 |
[Treatment of migraine in neurological practice].
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Migraine Disorders; Oxytocics | 1959 |
Headache clinics No. VIII. Vascular headache: ergotamine tartrate, caffeine and antiemetic combnation as an adjunct in therapy.
Topics: Anti-Allergic Agents; Antiemetics; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Headache; Histamine H1 Antagonists; Oxytocics; Vascular Headaches | 1960 |
Morning headache.
Topics: Biomedical Research; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Headache; Oxytocics | 1960 |
Quaternary ammonium salts of 8-(dialkylaminoalkoxy)-theobromines and -caffeines as curariform agents.
Topics: Caffeine; Cardiovascular Agents; Muscle Relaxants, Central; Quaternary Ammonium Compounds; Salts; Theobromine | 1959 |
[Clinical experiences with a new phenacetin-free combination analgesic (Solco 7)].
Topics: Aminopyrine; Analgesics; Caffeine; Cardiovascular Agents; Humans; Muscle Relaxants, Central; Phenacetin; Salicylamides | 1962 |
[ON THE INTERVAL TREATMENT OF MIGRAINE].
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Migraine Disorders; Phenytoin | 1964 |
DRUGS FOR HEADACHE OF MIGRAINOUS, VASCULAR OR MUSCULAR ORIGIN.
Topics: Aspirin; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Headache; Humans; Meprobamate; Methysergide; Migraine Disorders; Oxytocics; Pharmacology; Phenacetin; Phenobarbital; Scopolamine; Toxicology | 1964 |
ACUTE ERGOTISM: REPORT OF A CSE AND A REVIEW OF THE LITERATURE.
Topics: Anesthesia; Anesthesia, Conduction; Anesthesiology; Autonomic Nerve Block; Caffeine; Cardiovascular Agents; Dihydroergotoxine; Ergot Alkaloids; Ergotamine; Ergotism; Gastric Lavage; Humans; Neurologic Manifestations; Penicillins; Tolazoline; Toxicology; Vasodilator Agents | 1964 |
Pentergot, a new agent for the symptomatic treatment of migraine.
Topics: Barbiturates; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Humans; Migraine Disorders | 1955 |
[Ergotamine tartrate with caffeine in therapy of migraine attacks].
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Migraine Disorders; Oxytocics; Social Behavior | 1955 |
A new agent for aborting attacks of migraine.
Topics: Animals; Behavior, Animal; Caffeine; Cardiovascular Agents; Ergot Alkaloids; Migraine Disorders; Scopolamine; Social Behavior | 1960 |
Ephedra: heart dangers in disguise.
Topics: Caffeine; Cardiovascular Agents; Consumer Product Safety; Dietary Supplements; Ephedra; Humans; Product Labeling; United States; United States Food and Drug Administration | 2004 |
Treatment of migraine; with special reference to ergotamine tartrate-caffeine rectal suppositories.
Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Humans; Migraine Disorders; Suppositories; Tartrates | 1952 |
Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy.
Topics: Caffeine; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cardiovascular Agents; Cell Size; Combined Modality Therapy; Heart Failure; Heart Transplantation; Heart Ventricles; Heart-Assist Devices; Humans; Ion Transport; Myocytes, Cardiac; Remission Induction; Sarcoplasmic Reticulum; Ventricular Dysfunction, Left | 2004 |
An effective symptomatic treatment of migraine.
Topics: Caffeine; Cardiovascular Agents; Chloral Hydrate; Ergot Alkaloids; Migraine Disorders; Oxytocics; Treatment Outcome | 1962 |
Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
Topics: Animals; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Caffeine; Camellia sinensis; Cardiovascular Agents; Catechin; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Fibrosis; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Heart Diseases; Hypoglycemic Agents; L-Lactate Dehydrogenase; Maillard Reaction; Male; Myocardium; Plant Extracts; Plant Leaves; Protein Processing, Post-Translational; Rats; Rats, Wistar; Solubility; Spectrometry, Fluorescence | 2007 |
The effects of caffeine on the preterm sheep ductus arteriosus.
Topics: Animals; Caffeine; Cardiovascular Agents; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Gestational Age; Indomethacin; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Pregnancy; Prostaglandins; Sheep; Vasoconstriction | 2007 |
Potential for biodegradation and sorption of acetaminophen, caffeine, propranolol and acebutolol in lab-scale aqueous environments.
Topics: Acebutolol; Acetaminophen; Adsorption; Biodegradation, Environmental; Caffeine; Cardiovascular Agents; Central Nervous System Stimulants; Clinical Laboratory Techniques; Environmental Restoration and Remediation; Propranolol; Sensory System Agents; Water Pollutants, Chemical | 2010 |
Caffeine consumption does not have an effect on digital microvascular perfusion assessed by laser Doppler imaging on healthy volunteers: a pilot study.
Topics: Adult; Caffeine; Cardiovascular Agents; Fingers; Healthy Volunteers; Humans; Laser-Doppler Flowmetry; Microvessels; Middle Aged; Pilot Projects; Young Adult | 2015 |
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.
Topics: Action Potentials; Aniline Compounds; Animals; Benzazepines; Caffeine; Calcium; Cardiovascular Agents; Cell Differentiation; Cell Line; Cellular Reprogramming; Connexin 43; Dependovirus; Genetic Vectors; Humans; Induced Pluripotent Stem Cells; Isoproterenol; Ivabradine; Microtubules; Myocytes, Cardiac; Patch-Clamp Techniques; Phenyl Ethers; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Tetracaine; Transfection | 2015 |
Re: Knight R, Pagkalos J, Timmons C et al. Caffeine consumption does not have an effect on digital microvascular perfusion assessed by laser Doppler imaging on healthy volunteers: a pilot study. J Hand Surg Eur. 2015, 40: 412-5.
Topics: Caffeine; Cardiovascular Agents; Fingers; Humans; Microvessels | 2016 |
Reply. Re: Knight R, Pagkalos J, Timmons C et al. Caffeine consumption does not have an effect on digital microvascular perfusion assessed by laser Doppler imaging on healthy volunteers: a pilot study. J Hand Surg Eur. 2015, 40: 412-5.
Topics: Caffeine; Cardiovascular Agents; Fingers; Humans; Microvessels | 2016 |
Multiscale Determinants of Delayed Afterdepolarization Amplitude in Cardiac Tissue.
Topics: Aniline Compounds; Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Calcium Signaling; Cardiovascular Agents; Computer Simulation; Fluorescent Dyes; Intracellular Space; Male; Membrane Potentials; Models, Cardiovascular; Myocytes, Cardiac; Patch-Clamp Techniques; Rabbits; Sarcoplasmic Reticulum; Voltage-Sensitive Dye Imaging; Xanthenes | 2017 |